Found 8 matching trials
Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs
PHASE1This study will evaluate long-term safety and tolerability of pasireotide L...
Location
Novartis Investigative Site
Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET
PHASE2This study will estimate the treatment effect of everolimus in combination ...
Location
Dana Farber Cancer Institute SC-2
Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer
PHASE2The purpose of this study is to determine the effectiveness of two anticanc...
Location
Emory University Hospital Midtown
3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial
PHASE2This was a multicenter, randomized, phase II study evaluating Everolimus or...
Location
Novartis Investigative Site
RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma
PHASE2The purpose of this study is to find out what effects, good and/or bad, the...
Location
Memorial Sloan Kettering Cancer Center
Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
PHASE2The purpose of this study is to estimate the time to disease progression wh...
Location
Moffitt Cancer Center
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
PHASE1The purpose of this research study is to determine the safety of the combin...
Location
Beth Israel Deaconess Medical Center
Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs
PHASE1The purpose of this study is to assess the safety and tolerability of pasir...
Location
Novartis Investigative Site